|
PPP1R13B expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62436730732907E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
<1E-12 |
| Normal-vs-Stage2 |
1.7386999950908E-08 |
| Normal-vs-Stage3 |
<1E-12 |
| Normal-vs-Stage4 |
<1E-12 |
| Stage1-vs-Stage2 |
2.192100E-04 |
| Stage1-vs-Stage3 |
5.906400E-01 |
| Stage1-vs-Stage4 |
1.935880E-03 |
| Stage2-vs-Stage3 |
2.996500E-04 |
| Stage2-vs-Stage4 |
3.93859999947566E-07 |
| Stage3-vs-Stage4 |
8.185500E-02 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
<1E-12 |
| Normal-vs-AfricanAmerican |
7.4259043358893E-11 |
| Normal-vs-Asian |
1.62447832963153E-12 |
| Caucasian-vs-AfricanAmerican |
6.309200E-01 |
| Caucasian-vs-Asian |
6.474000E-01 |
| AfricanAmerican-vs-Asian |
8.357800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
<1E-12 |
| Normal-vs-Female |
1.6242562850266E-12 |
| Male-vs-Female |
7.904000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
<1E-12 |
| Normal-vs-Age(41-60Yrs) |
<1E-12 |
| Normal-vs-Age(61-80Yrs) |
1.62447832963153E-12 |
| Normal-vs-Age(81-100Yrs) |
1.543499994483E-08 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.802970E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.341500E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.168200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.998600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.685970E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.445610E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.07829999995701E-06 |
| Classical-VS-Follicular |
4.80990000051307E-07 |
| Classical-VS-Other |
8.564200E-01 |
| Classical-VS-Normal |
<1E-12 |
| Tall-VS-Follicular |
2.33102426250298E-12 |
| Tall-VS-Other |
3.400300E-02 |
| Tall-VS-Normal |
1.62458935193399E-12 |
| Follicular-VS-Other |
1.054010E-02 |
| Follicular-VS-Normal |
3.48350015499932E-10 |
| Other-VS-Normal |
1.29029999995645E-06 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
<1E-12 |
| Normal-vs-N1 |
1.62458935193399E-12 |
| N0-vs-N1 |
2.00709999953474E-07 |
|
|
